Rainbow Childrens Medicare announces AGM and e-voting dates

1 min read     Updated on 08 Jul 2026, 03:01 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Rainbow Childrens Medicare Limited announced its 28th AGM on July 29, 2026, to be held via video conferencing. The Board recommended a final dividend of ₹3.5 per equity share for FY26, subject to shareholder approval. Remote e-voting is available from July 25 to July 28, 2026.

powered bylight_fuzz_icon
44084870

*this image is generated using AI for illustrative purposes only.

Rainbow Childrens Medicare Limited will hold its 28th Annual General Meeting (AGM) on Wednesday, July 29, 2026, at 10:00 AM IST through video conferencing. The meeting will be conducted in compliance with the Companies Act, 2013, and relevant SEBI regulations, permitting the event without physical presence at a common venue. The corporate office in Banjara Hills, Hyderabad, will serve as the deemed venue for the proceedings.

The Board of Directors, at its meeting held on May 23, 2026, recommended a final dividend of ₹3.5 per equity share for the financial year ended March 31, 2026. This dividend distribution is subject to the approval of the members at the upcoming AGM. Shareholders whose names appear in the Register of Members or the list of beneficial owners maintained by depositories as of Tuesday, July 21, 2026, will be eligible to receive the payout.

E-Voting and Meeting Logistics

The company has engaged National Securities Depository Limited (NSDL) to facilitate remote e-voting and e-voting during the AGM. The remote e-voting period commences on Saturday, July 25, 2026, at 9:00 AM IST and concludes on Tuesday, July 28, 2026, at 5:00 PM IST. The voting rights of members are determined based on their shareholding as of the cut-off date, Wednesday, July 22, 2026. Members who have cast their votes remotely may attend the meeting but will not be entitled to vote again.

In compliance with Ministry of Corporate Affairs and SEBI circulars, the notice for the 28th AGM and the Annual Report for FY 2025-26 were dispatched electronically on Saturday, July 4, 2026. Shareholders with registered email addresses received these documents directly, while a letter containing a QR code and web-link was sent to those without registered email addresses. The company confirmed that there are no shareholders holding shares in physical form as of the notice date.

Dividend and Taxation Details

The company has specified that dividends will be paid exclusively through electronic mode. Shareholders are advised to ensure their bank account details, including account number, bank name, branch details, and IFSC code, are updated with their respective depository participants to facilitate timely credit. Additionally, pursuant to the provisions of the Income-tax Act, 2025, the dividend will be paid after deduction of tax at source at applicable rates. Members must ensure their Permanent Account Number (PAN) and residential status are updated to determine the correct tax deduction rate.

Historical Stock Returns for Rainbow Childrens Medicare

1 Day5 Days1 Month6 Months1 Year5 Years
+1.85%+0.88%+6.49%+25.96%-2.86%+232.45%

How will the recommended dividend impact Rainbow Children's Medicare's cash flow and future investment plans?

What strategic initiatives or growth targets is the company likely to outline during the AGM for FY 2026-27?

How might changes in the Income-tax Act, 2025, affect shareholder net returns and dividend attractiveness?

Rainbow Childrens Medicare
View Company Insights
View All News
like15
dislike

Rainbow Children's Medicare FY2026 Annual Report: Revenue Rises 12.4%, PAT Up 15.3%

4 min read     Updated on 07 Jul 2026, 04:18 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Rainbow Children's Medicare released its FY2026 Integrated Annual Report, reporting record consolidated revenue of ₹17,030.77 million (+12.35%), EBITDA of ₹5,441.67 million (+11.08%), and PAT of ₹2,815.44 million (+15.28%). The company added 440 beds, completed two strategic acquisitions, and recommended a final dividend of ₹3.50 per share, with the 28th AGM scheduled for July 29, 2026.

powered bylight_fuzz_icon
44857468

*this image is generated using AI for illustrative purposes only.

Rainbow Children's Medicare has released its Integrated Annual Report for FY2025-26, providing shareholders access via its official investor relations portal. The report covers the period from April 1, 2025 to March 31, 2026 and was approved by the Board of Directors on May 23, 2026. Company Secretary and Compliance Officer Shreya Mitra signed the related intimation on July 4, 2026, in compliance with Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholders without registered email addresses can access the report through the company's official web link.

Report Access Details

Shareholders can access the Integrated Annual Report for FY2025-26 through the following official channel:

Access Method: Details
Web-link: https://www.rainbowhospitals.in/investors-relations/annual-reports
Registrar: M/s. Kfin Technologies Limited
Registered Office: 8-2-120/103/1, Survey No. 403, Road No. 2, Banjara Hills, Hyderabad-500034, Telangana

Financial Performance

FY2026 marked a strong financial year for Rainbow Children's Medicare, with the company delivering its highest-ever revenue, EBITDA, and PAT on a consolidated basis. The following table summarises the key consolidated financial metrics:

Metric: FY2026 FY2025 FY2024
Revenue (₹ million): 17,031 15,159 12,969
EBITDA (₹ million): 5,442 4,899 4,289
PAT (₹ million): 2,815 2,442 2,183
EBITDA Margin (%): 32.00 32.30 33.10
PAT Margin (%): 16.50 16.10 16.80
ROCE (%): 26.07 26.95 27.60
ROE (%): 18.07 17.85 18.70
Dividend per Share (₹): 3.50* 3.00 3.00

*Subject to shareholder approval at the ensuing AGM.

Revenue grew 12.35% to ₹17,030.77 million, driven by a 6.22% rise in inpatient volumes, a 12.07% increase in outpatient volumes, and an 11.45% increase in Average Revenue per Occupied Bed (ARPOB). EBITDA grew 11.08% to ₹5,441.67 million, while consolidated net profit after tax rose 15.28% to ₹2,815.44 million. On a standalone basis, income rose 5.70% to ₹15,891.14 million and net profit after tax grew 5.23% to ₹2,500.16 million.

Operational Highlights

FY2026 was a landmark year for network expansion. Rainbow added 440 capacity beds — the highest annual addition in its history — taking total bed capacity to 2,375 (excluding the 60-bed HRBR hospital in Bengaluru, which commenced operations on May 1, 2026). Key operational metrics are presented below:

Metric: FY2026 FY2025 FY2024
Bed Capacity (Nos.): 2,375 1,935 1,677
Operational Beds (Nos.): 1,523 1,324
Occupancy Rate (%): 50.50 47.90 46.30
In-patient Admissions (Nos.): 104,514 98,395 87,736
Out-patient Consultations (Nos.): 1,598,970 1,426,733 1,277,087
ARPOB (₹ per day): 60,141 55,853 53,962
Average Length of Stay (Days): 2.80 2.70 2.60
Pediatric Surgeries (Nos.): 7,324 7,239 7,088
Gynecology Surgeries (Nos.): 10,140 8,435 7,579

The company also completed two strategic acquisitions during the year: Prashanthi Medicare Private Limited (Warangal, Telangana; 100 beds; effective July 1, 2025) for approximately ₹33 crores, and Pratiksha Women & Child Care Hospital Private Limited (Guwahati, Northeast; 150 beds; effective August 18, 2025) for approximately ₹171 crores. These acquisitions contributed ₹191.52 million and ₹648.70 million to consolidated revenue, respectively.

Capital Allocation and Balance Sheet

As of March 31, 2026, cash, cash equivalents, fixed deposits, and mutual fund investments stood at ₹5,942 million. Capital expenditure during FY2026 amounted to ₹2,170 million, directed towards expanding and strengthening capabilities across existing and upcoming hospitals. The company's net block of assets grew by ₹791.51 million to ₹8,924.33 million, while capital work-in-progress stood at ₹757.51 million, linked to upcoming projects in Gurugram, Pune, and Hennur.

Capital Metric: Details
Cash & Equivalents (₹ million): 5,942
Capital Expenditure FY2026 (₹ million): 2,170
Net Block of Assets (₹ million): 8,924.33
Capital Work-in-Progress (₹ million): 757.51
ICRA Credit Rating: [ICRA]AA (Stable)

The Board has recommended a final dividend of ₹3.50 per equity share of face value ₹10 each (35% of face value) for FY2025-26, subject to shareholder approval at the 28th Annual General Meeting scheduled for July 29, 2026. The record date for dividend entitlement has been fixed as July 21, 2026.

Network Expansion and Strategic Outlook

Rainbow's network as of March 31, 2026, spans 24 hospitals and 5 clinics across 9 cities, with a strong hub-and-spoke model anchoring specialized pediatric and perinatal care. Key upcoming projects include a regional hub hospital in Coimbatore (approximately 130 beds, expected H2 FY2028), hub and spoke hospitals in Gurugram (approximately 325 beds and 125 beds respectively), and a regional hub hospital in Pune (approximately 150 beds). The company aims to add over 2,500 beds over the next five years, targeting a network of approximately 5,000 beds with an investment of around ₹2,200 crore.

As of March 31, 2026, the company employed 6,397 permanent and contract staff, with women constituting 62% of the total workforce. The Board also noted that the company's ESOP Scheme 2025 was implemented during the year, with 246,470 stock options granted across three tranches.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE961O01016/4e1945aa-555d-4287-ab65-8fa14c169615.pdf

Historical Stock Returns for Rainbow Childrens Medicare

1 Day5 Days1 Month6 Months1 Year5 Years
+1.85%+0.88%+6.49%+25.96%-2.86%+232.45%

How will the recent significant capital expenditures and the planned ₹2,200 crore investment impact the company's free cash flow and debt levels over the next five years?

With the occupancy rate rising to 50.50% alongside the addition of 440 beds, what is the expected timeline for these new assets to reach full operational efficiency and stabilize EBITDA margins?

Given the geographic expansion into new regions like the Northeast and North India, what strategies will be employed to replicate the hub-and-spoke success seen in existing markets?

Rainbow Childrens Medicare
View Company Insights
View All News
like18
dislike

More News on Rainbow Childrens Medicare

1 Year Returns:-2.86%